Distinct circulating cytokine/chemokine profiles correlate with clinical benefit of immune checkpoint inhibitor monotherapy and combination therapy in advanced non‐small cell lung cancer

BACKGROUND: An ever‐increasing number of efforts are focused on identifying effective biomarkers for immune checkpoint inhibitors (ICIs). Cytokines and chemokines are critical to tumor growth, metastasis, tumor angiogenesis, and the immune response against tumor cells. In the study here, we determin...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Yue, Li, Shixun, Xiao, He, Xiong, Yanli, Lu, Xianfeng, Yang, Xiao, Luo, Wei, Luo, Jiamin, Zhang, Shiheng, Cheng, Yi, Zhang, Lei, Dai, Xiaoyan, Yang, Yuxin, Wang, Dong, Li, Mengxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278479/
https://www.ncbi.nlm.nih.gov/pubmed/37062076
http://dx.doi.org/10.1002/cam4.5918

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278479/
https://www.ncbi.nlm.nih.gov/pubmed/37062076
http://dx.doi.org/10.1002/cam4.5918

Ejemplares similares